Top of this page
Skip navigation, go straight to the content

Cimzia® (certolizumab pegol)

Therapeutic focus

Crohn's Disease, Rheumatoid Arthritis, Psoriasis

Type of molecule

NBE (PEGylated Fab' anti-TNF-alpha)

Mode of action

Selectively neutralises the pro-inflammatory effect of tumour necrosis factor alpha (TNFα)